| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chia-Yih Liu, Nan-Ying Chiu, Ching-Kuan Wu, Lo-Ming Yuan, Mei-Chun Hsiao, Oscar Lia. Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan. International clinical psychopharmacology. vol 18. issue 1. 2003-04-15. PMID:12490775. |
risperidone and olanzapine-administration data were collected for schizophrenia patients treated at four taiwanese medical centres. |
2003-04-15 |
2023-08-12 |
Not clear |
| Edyta J Frackiewicz, John M Herrera, John J Sramek, Yasmine Collazo, William B Lawso. Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study. Psychiatry. vol 65. issue 4. 2003-04-14. PMID:12530340. |
risperidone in the treatment of hispanic inpatients with schizophrenia: a pilot study. |
2003-04-14 |
2023-08-12 |
Not clear |
| Edyta J Frackiewicz, John M Herrera, John J Sramek, Yasmine Collazo, William B Lawso. Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study. Psychiatry. vol 65. issue 4. 2003-04-14. PMID:12530340. |
in this pilot study, 10 hispanic and 8 non-hispanic patients with schizophrenia were enrolled in a double-blind, parallel-group, inpatient risperidone dosing (daily versus twice daily) trial with the novel antipsychotic risperidone. |
2003-04-14 |
2023-08-12 |
Not clear |
| G J E Schmitt, E M Meisenzahl, S Dresel, K Tatsch, B Rossmüller, T Frodl, U W Preuss, K Hahn, H J Mölle. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. Journal of psychopharmacology (Oxford, England). vol 16. issue 3. 2003-04-07. PMID:12236625. |
twenty inpatients suffering from schizophrenia or schizoaffective psychosis according to dsm iv/icd-10 criteria were treated with clinically recommended doses of risperidone and compared with 13 inpatients treated with up to 20 mg olanzapine. |
2003-04-07 |
2023-08-12 |
human |
| Jane K McGavin, Karen L Go. Aripiprazole. CNS drugs. vol 16. issue 11. 2003-04-04. PMID:12383035. |
in patients with acute relapse of schizophrenia or schizoaffective disorder, aripiprazole 15 to 30 mg/day was at least as effective as haloperidol 10 mg/day and had similar efficacy to risperidone 6 mg/day in well designed, 4-week, placebo-controlled trials. |
2003-04-04 |
2023-08-12 |
Not clear |
| Veena Kumari, Tonmoy Sharm. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology. vol 162. issue 2. 2003-03-26. PMID:12110987. |
currently, available data on the differential effects of typical and atypical antipsychotics suggest that atypical antipsychotics, in particular clozapine and risperidone, may be more effective than typical antipsychotics in improving ppi deficits in schizophrenia. |
2003-03-26 |
2023-08-12 |
Not clear |
| Ann L Sharpley, Zubin Bhagwagar, Sepehr Hafizi, W Richard Whale, Harm J Gijsman, Philip J Cowe. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. The Journal of clinical psychiatry. vol 64. issue 2. 2003-03-26. PMID:12633128. |
the atypical antipsychotic agent risperidone has beneficial effects on mood in patients with schizophrenia. |
2003-03-26 |
2023-08-12 |
human |
| R H Bouchar. [Longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation]. L'Encephale. vol 28 Spec No 2 Pt 2. 2003-03-25. PMID:12587355. |
[longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation]. |
2003-03-25 |
2023-08-12 |
Not clear |
| I De Beauchamp, E Giraud-Baro, C Gur. [RODOS: risperidone olanzapine drug outcome studies in schizophrenia]. L'Encephale. vol 28 Spec No 2 Pt 2. 2003-03-25. PMID:12587356. |
[rodos: risperidone olanzapine drug outcome studies in schizophrenia]. |
2003-03-25 |
2023-08-12 |
Not clear |
| Alan Brevik, Debra Farve. Atypical antipsychotic induced mild hypothermia. South Dakota journal of medicine. vol 56. issue 2. 2003-03-25. PMID:12621956. |
this is a case report of subtle, mild hypothermia in a 54-year old female patient receiving risperidone for schizophrenia. |
2003-03-25 |
2023-08-12 |
Not clear |
| Robert Paul Liberman, Daniel Gutkind, Jim Mintz, Michael Green, B D Marshall, Mary Jane Robertson, Jeffery Hayde. Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia. Comprehensive psychiatry. vol 43. issue 6. 2003-03-21. PMID:12439835. |
impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia. |
2003-03-21 |
2023-08-12 |
human |
| Robert Paul Liberman, Daniel Gutkind, Jim Mintz, Michael Green, B D Marshall, Mary Jane Robertson, Jeffery Hayde. Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia. Comprehensive psychiatry. vol 43. issue 6. 2003-03-21. PMID:12439835. |
we tested whether risperidone was associated with greater improvements than haloperidol in activities of daily living (adls) among persons having treatment-refractory schizophrenia. |
2003-03-21 |
2023-08-12 |
human |
| D K Lim, R Mahendra. Risperidone and megacolon. Singapore medical journal. vol 43. issue 10. 2003-03-21. PMID:12587709. |
a 44-year-old man suffering from schizophrenia was treated with risperidone and developed gross abdominal distension after twenty-five days. |
2003-03-21 |
2023-08-12 |
Not clear |
| Daniel E Casey, David G Daniel, Adel A Wassef, Katherine A Tracy, Patricia Wozniak, Kenneth W Sommervill. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 28. issue 1. 2003-03-17. PMID:12496955. |
effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. |
2003-03-17 |
2023-08-12 |
Not clear |
| Daniel E Casey, David G Daniel, Adel A Wassef, Katherine A Tracy, Patricia Wozniak, Kenneth W Sommervill. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 28. issue 1. 2003-03-17. PMID:12496955. |
patients (n = 249) who met dsm-iv criteria for schizophrenia were randomly assigned to receive olanzapine monotherapy, risperidone monotherapy, divalproex plus olanzapine, or divalproex plus risperidone for 28 days. |
2003-03-17 |
2023-08-12 |
Not clear |
| Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Leslie Citrome, Brian Sheitman, Joseph P McEvoy, Thomas B Cooper, Miranda Chakos, Jeffrey A Lieberma. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. The American journal of psychiatry. vol 160. issue 2. 2003-03-04. PMID:12562575. |
the authors' goal was to assess the effects of clozapine, olanzapine, risperidone, and haloperidol on glucose and cholesterol levels in hospitalized patients with schizophrenia or schizoaffective disorder during a randomized double-blind 14-week trial. |
2003-03-04 |
2023-08-12 |
Not clear |
| Norio Yasui-Furukori, Tsuyoshi Kondo, Kazuo Mihara, Akihito Suzuki, Yoshimasa Inoue, Ronald De Vries, Sunao Kanek. Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidone. Journal of clinical pharmacology. vol 42. issue 10. 2003-02-13. PMID:12362921. |
both haloperidol and risperidone have been widely used in the treatment of schizophrenia. |
2003-02-13 |
2023-08-12 |
human |
| Daniel Sechter, Joseph Peuskens, Odile Fleurot, Werner Rein, Yves Lecrubie. Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 27. issue 6. 2003-01-24. PMID:12464464. |
amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study. |
2003-01-24 |
2023-08-12 |
Not clear |
| Daniel Sechter, Joseph Peuskens, Odile Fleurot, Werner Rein, Yves Lecrubie. Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 27. issue 6. 2003-01-24. PMID:12464464. |
this multicenter, double-blind, randomized study evaluated the efficacy, safety and functional effects of two atypical antipsychotics, amisulpride and risperidone, in patients with chronic schizophrenia (dsm iv) with a recent worsening of symptoms. |
2003-01-24 |
2023-08-12 |
Not clear |
| Hitoshi Takahashi, Takio Sugita, Hisashi Higuchi, Tetsuo Shimiz. Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial. Human psychopharmacology. vol 17. issue 2. 2003-01-17. PMID:12404698. |
we investigated the efficacy and safety of augmenting risperidone with fluvoxamine for the treatment of residual positive and negative symptoms in patients with chronic schizophrenia who had shown an incomplete response to risperidone. |
2003-01-17 |
2023-08-12 |
Not clear |